Business

agilon health Reports Third Quarter 2025 Results and Re-Establishes Full Year Outlook

WESTERVILLE, Ohio, November 04, 2025--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced results for the third quarter ended September 30, 2025 and provided a full-year 2025 outlook.

articleAgilon Health, Inc.November 4, 202521/company/agilon-health-inc/news/agilon-health-reports-third-quarter-210500669
agilon health Reports Third Quarter 2025 Results and Re-Establishes Full Year Outlook

About this update from Agilon Health, Inc.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1281,"height":200,"url":"https://media.zenfs.com/en/business-wire.com/dab7efdf7a5fac4272df24606cc45954"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/wWhtN5GCf1qtFwzpgnIayg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTE1MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/dab7efdf7a5fac4272df24606cc45954","width":960,"height":150},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/gMhVdntVjCazpzIChTH8NA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD0zNzQ7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/dab7efdf7a5fac4272df24606cc45954","width":1200,"height":187}},"lazy":false},{"type":"text","content":"Continued Progress on Transformation Initiatives Including the Execution of $30 million in 2026 Operating Cost Reductions","length":121,"tagName":"p","attribs":{}},{"type":"text","content":"WESTERVILLE, Ohio, November 04, 2025--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced results for the third quarter ended September 30, 2025 and provided a full-year 2025 outlook.","length":284,"tagName":"p"},{"type":"text","content":""In the third quarter we made tangible progress executing on our transformation initiatives while continuing to absorb the impact of historical challenges. We have enhanced data visibility, instilled a greater financial discipline in our payor contracting processes, and reduced operating costs," said Ronald A. Williams, Executive Chair. "We are building a more streamlined, agile, accountable, and performance-driven organization. These efforts are already delivering measurable impact—reducing operating expenses by an expected $30 million in 2026, and supporting strong performance expectations for our BOI, clinical, and quality initiatives, with additional potential from more favorable rates, contract economics and payer bids. We remain focused on driving improved and sustainable financial performance in a dynamic healthcare market."","length":863,"tagName":"p"},{"type":"text","content":"Third Quarter 2025 Results:","length":27,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"The third quarter of 2025 reflects the impact of lower-than-exp...

More updates from Agilon Health, Inc.

Medicare AdvantageTotal revenueGross profitEBITDAagilon health, inc.Adjusted EBITDA